Principal Investigator
|
Title
|
Organization
|
Status
|
ID
|
| Schwenkglenks, Matthias |
Cost-effectiveness of novel ophthalmology drugs |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
4491703 |
| Schwenkglenks, Matthias |
Cost-effectiveness of novel multiple sclerosis drug |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
4491692 |
| Schwenkglenks, Matthias |
ENDOSCAPE, a clinically applicable non-viral gene delivery technology |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
4491519 |
| Schwenkglenks, Matthias |
Impact of targeted therapy in patients with metastatic lung cancer |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
4473765 |
| Schwenkglenks, Matthias |
Cost-effectiveness of hyperkalemia treatment |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
3529269 |
| Schwenkglenks, Matthias |
Cost of HCV treatment in Switzerland |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
3511583 |
| Schwenkglenks, Matthias |
OPERAM: Optimising PharmacothERApy in the Multimorbid elderly |
Departement Public Health / Pharmazeutische Medizin ECPM,
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
3032139 |
| Schwenkglenks, Matthias |
Cost-effectivness of chronic heart failure treatment |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
3008122 |
| Schwenkglenks, Matthias |
Cost-effectiveness analysis of acute heart failure treatment |
Departement Public Health / Pharmazeutische Medizin (Szucs) |
Completed |
2250318 |
| Pfeil, Alena |
Alzheimer's dementia: budget-impact and cost-utility analysis of a combination treatment of a cholinesterase inhibitor and memantine in Switzerland |
Departement Public Health / Pharmazeutische Medizin ECPM |
Completed |
1201959 |
| Blank, Patricia R. |
Hepatocellular and renal cell carcinoma treatment strategies: a review of health economic analyses |
Pharmazeutische Medizin ECPM |
Completed |
1201908 |
| Blank, Patricia R. |
Health-economic analysis of 13-valent pneumococcal vaccination among adults in Switzerland |
Pharmazeutische Medizin ECPM |
Completed |
1201893 |
| Blank, Patricia R.; Gutzwiller, Florian S. |
Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer |
Pharmazeutische Medizin ECPM |
Completed |
1201892 |
| Schwenkglenks, Matthias, Gutzwiller, Florian |
Methods to measure and value the benefit of medical technologies, drugs and interventions in Switzerland and other countries. |
Departement Public Health / Pharmazeutische Medizin ECPM |
Completed |
1201883 |
| Szucs, Thomas |
Cost variations among treatment options for patients with refractory myeloma previously treated with high-dose chemotherapy and autologous stem-cell transplantation ? An analysis from the US and the Swiss perspective |
Pharmazeutische Medizin ECPM |
Completed |
1201331 |
